Strategy Asset Managers’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,368
Closed -$647K 266
2025
Q4
$647K Sell
2,368
-21
-0.9% -$5.71K 0.11% 130
2025
Q3
$646K Buy
+2,389
New +$650K 0.12% 135
2024
Q2
Sell
-2,806
Closed -$604K 250
2024
Q1
$604K Buy
+2,806
New +$589K 0.13% 122
2019
Q3
Sell
-3,830
Closed -$743K 127
2019
Q2
$743K Sell
3,830
-9,632
-72% -$1.78M 0.21% 75
2019
Q1
$2.22M Sell
13,462
-2,407
-15% -$426K 0.5% 76
2018
Q4
$2.98M Sell
15,869
-454
-3% -$83.8K 0.73% 38
2018
Q3
$2.78M Buy
+16,323
New +$2.75M 0.56% 63

Other funds holding CME

Strategy Asset Managers's CME Position: Q1 2026 in Review

Strategy Asset Managers sold out of CME Group (CME) in Q1 2026, closing a stake of 2,368 shares — an estimated $647K sold.

Strategy Asset Managers first reported a position in CME in Q3 2018 and held it in 7 quarters. The position peaked at $2.98M in Q4 2018. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Strategy Asset Managers reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
  • Strategy Asset Managers sold 2,368 CME Group shares in Q1 2026, an estimated $647K.
  • Strategy Asset Managers first reported a position in CME Group in Q3 2018 and held it in 7 quarters.
  • Strategy Asset Managers's CME Group position peaked at $2.98M in Q4 2018.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Strategy Asset Managers's 13F filing for Q1 2026, filed 12 May 2026.